Articles:

Antisense oligonucleotides targeted to the human folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment

Mona S. Jhaveri, Antonina S. Rait, Koong-Nah Chung, Jane B. Trepel, and Esther H. Chang
Mol Cancer Ther 2004 3: 1505-1512 [Abstract] [Full Text] [PDF]  

The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical–dependent and Jun NH₂-terminal kinase–dependent mechanism

Xin-Yan Pei, Yun Dai, and Steven Grant
Mol Cancer Ther 2004 3: 1513-1524 [Abstract] [Full Text] [PDF]  

Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin

Alexandre I. Belenkov, George Shenouda, Ekatarina Rizhevskaya, Denis Cournoyer, Jean-Philippe Belzile, Luis Souhami, Slobodan Devic, and Terry Y.K. Chow
Mol Cancer Ther 2004 3: 1525-1532 [Abstract] [Full Text] [PDF]  

Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity

James Turkson, Shumin Zhang, Jay Palmer, Heidi Kay, Joseph Stanko, Linda B. Mora, Said Sebti, Hua Yu, and Richard Jove
Mol Cancer Ther 2004 3: 1533-1542 [Abstract] [Full Text] [PDF]  

Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells

Im-Sook Song, Niramol Savaraj, Zahid H. Siddik, Peiman Liu, Yingjie Wei, Chun Jing Wu, and Macus Tien Kuo
Mol Cancer Ther 2004 3: 1543-1549 [Abstract] [Full Text] [PDF]  

Different proteome pattern of epidermal growth factor receptor–positive colorectal cancer cell lines that are responsive and nonresponsive to C225 antibody treatment

Sergej Skvortsov, Bettina Sarg, Judith Loeffler-Ragg, Ira Skvortsova, Herbert Lindner, Helmut Werner Ott, Peter Lukas, Karl Illmensee, and Heinz Zwierzina
Mol Cancer Ther 2004 3: 1551-1558 [Abstract] [Full Text] [PDF]  

A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy

Rhona Stein and David M. Goldenberg
Mol Cancer Ther 2004 3: 1559-1564 [Abstract] [Full Text] [PDF]  

In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles

Chee Onn Leong, Marie Suggitt, David J. Swaine, Michael C. Bibby, Malcolm F.G. Stevens, and Tracey D. Bradshaw
Mol Cancer Ther 2004 3: 1565-1575 [Abstract] [Full Text] [PDF]  

Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference

P.L. Rachel Ee, Xiaolong He, Douglas D. Ross, and William T. Beck
Mol Cancer Ther 2004 3: 1577-1584 [Abstract] [Full Text] [PDF]  

Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer

Minna Tanner, Anita I. Kapanen, Teemu Junttila, Olayinka Raheem, Seija Grenman, Jussi Elo, Klaus Elenius, and Jorma Isola
Mol Cancer Ther 2004 3: 1585-1592 [Abstract] [Full Text] [PDF]  

Doxorubicin-formaldehyde conjugates targeting _vß₃ integrin

David J. Burkhart, Brian T. Kalet, Michael P. Coleman, Glen C. Post, and Tad H. Koch
Mol Cancer Ther 2004 3: 1593-1604 [Abstract] [Full Text] [PDF]  

Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin

David J. VanderWeele, Rixin Zhou, and Charles M. Rudin
Mol Cancer Ther 2004 3: 1605-1613 [Abstract] [Full Text] [PDF]  

Epidermal growth factor receptor–related peptide inhibits growth of PC-3 prostate cancer cells

Dorota J. Marciniak, Arun K. Rishi, Fazlul H. Sarkar, and Adhip P.N. Majumdar
Mol Cancer Ther 2004 3: 1615-1621 [Abstract] [Full Text] [PDF]  

Highly efficient delivery of p16 antitumor peptide into aggressive leukemia/lymphoma cells using a novel transporter system

Eisaku Kondo, Masao Seto, Kazuhiro Yoshikawa, and Tadashi Yoshino
Mol Cancer Ther 2004 3: 1623-1630 [Abstract] [Full Text] [PDF]  

The ex vivo characterization of XR5944 (MLN944) against a panel of human clinical tumor samples

Federica Di Nicolantonio, Louise A. Knight, Pauline A. Whitehouse, Stuart J. Mercer, Sanjay Sharma, Peter A. Charlton, David Norris, and Ian A. Cree
Mol Cancer Ther 2004 3: 1631-1637 [Abstract] [Full Text] [PDF]  

KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth

Kazuhide Nakamura, Atsushi Yamamoto, Masaru Kamishohara, Kazumi Takahashi, Eri Taguchi, Toru Miura, Kazuo Kubo, Masabumi Shibuya, and Toshiyuki Isoe
Mol Cancer Ther 2004 3: 1639-1649 [Abstract] [Full Text] [PDF]  

Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor–related apoptosis-inducing ligand–induced apoptosis in melanoma cells

Susan K. Gillespie, Xu Dong Zhang, and Peter Hersey
Mol Cancer Ther 2004 3: 1651-1658 [Abstract] [Full Text] [PDF]  

Camptothecin- and etoposide-induced apoptosis in human leukemia cells is independent of cell death receptor-3 and -4 aggregation but accelerates tumor necrosis factor–related apoptosis-inducing ligand–mediated cell death

Stephane Bergeron, Myriam Beauchemin, and Richard Bertrand
Mol Cancer Ther 2004 3: 1659-1669 [Abstract] [Full Text] [PDF]  

Growth inhibitory effects of celecoxib in human umbilical vein endothelial cells are mediated through G₁ arrest via multiple signaling mechanisms

Ho-Pi Lin, Samuel K. Kulp, Ping-Hui Tseng, Ya-Ting Yang, Chi-Cheng Yang, Chang-Shi Chen, and Ching-Shih Chen
Mol Cancer Ther 2004 3: 1671-1680 [Abstract] [Full Text] [PDF]  

Diphtheria toxin-murine granulocyte-macrophage colony-stimulating factor–induced hepatotoxicity is mediated by Kupffer cells

Marlena M. Westcott, Ralph J. Abi-Habib, Kimberley A. Cohen, Mark C. Willingham, Shihui Liu, Thomas H. Bugge, Stephen H. Leppla, and Arthur E. Frankel
Mol Cancer Ther 2004 3: 1681-1689 [Abstract] [Full Text] [PDF]  

Enhanced efficacy of therapy with antisense BCL-2 oligonucleotides plus anti-CD20 monoclonal antibody in scid mouse/human lymphoma xenografts

Mitchell R. Smith, Fang Jin, and Indira Joshi
Mol Cancer Ther 2004 3: 1693-1699 [Abstract] [Full Text] [PDF]  

Commentary:

Confirmation and prevention of targeted toxicity by a recombinant fusion toxin

Robert J. Kreitman
Mol Cancer Ther 2004 3: 1691-1692 [Full Text] [PDF]  

Correction:

Article on anti-STAT3 and prostate cancer

Mol Cancer Ther 2004 3: 1701 [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.